| Asthma (n = 146) | COPD (n = 85) | ||
|---|---|---|---|
| Exacerbations in previous 12 months | Oral antibiotics and/or oral steroids per patient | 1.7 per patient (range: 0 -12) | 3.0 per patient (range: 0 -15) |
| Number of A&E attendances, n (mean/patient) | 33 (0.23) | 33 (0.39) | |
| Number of hospital admissions, n (mean/patient) | 14 (0.10) | 26 (0.31) | |
| Inhaler technique (n) | Good technique | 27.6% (40) | 23.8% (20) |
| Moderate technique | 16.5% (24) | 25.0% (21) | |
| Poor technique | 55.9% (81) | 51.2% (43) | |
| Beclomethasone dipropionate equivalence (BDP) | Pre review (range: 200–4000) | 1669.9mcg | NA |
| Post review (range: 400–2000) | 1044.1mcg | NA | |
| Smoking history (n) | Current | 24.7% (36) | 36.5% (31) |
| Quit rates (for ≥3months) post follow up | 50.0% (18) | 58.1% (18) | |
| Ex smoker | 17.8% (26) | 56.5% (48) | |
| Mean pack year history | 30.1 | 57.1 | |
| Mean adherence to medicines in previous 12 months (median) | Maintenance ICS/LABA or ICS | 7.9 (7.0) | 8.4 (8.0) |
| Long acting antimuscarinic | NA | 9.8 (10.0) | |
| Reliever inhaler | 9.3 (7.0) | 14.3 (12.5) | |
| Reliever Inhaler Use (times per day) | 2.2 | 3.0 | |
| On correct therapy based on symptoms, diagnosis and disease severity (n) | 24.0% (35) | 35.3% (30) | |
| If not on correct therapy, intervention made (n) | Step down | 74.8% (83) | NA |
| Stopping a part of treatment | 25.2% (28) | 67.3% (37) | |
| Querying the correct diagnosis | 7.2% (8) | 16.4% (9) | |
| BTS/SIGN Step 4–5 | 74% | NA | |
| FEV1% of predicted mean | NA | 51.5% | |
| Peak Expiratory Flow Rate | Baseline | 353.3 | NA |
| Follow Up | 375.5 | NA | |
| ACT score mean | Baseline | 15.8 | NA |
| Follow Up | 17.3 | NA | |
| CAT score mean | Baseline | NA | 21.0 |
| Follow Up | NA | 18.9 | |
| Night time wakening | Baseline | 39.7% (58) | 21.2% (18) |
| Follow Up | 17.6% (26) | 20.0% (17) | |
| Reliever inhaler use per day (mean) | Baseline | 2.2 | 3.0 |
| Follow Up | 1.3 | 1.9 | |